BofA: Investors pour into bonds, pull back from crypto
On March 7, 2025, John C. Duffy, General Counsel of Olaplex Holdings , Inc. (NASDAQ:OLPX), a beauty company with impressive gross profit margins of 71%, executed a sale of 35,013 shares of the company’s common stock. According to InvestingPro analysis, the company, currently valued at $1 billion, appears undervalued based on its Fair Value metrics. The transaction, detailed in a recent SEC Form 4 filing, was conducted at a price of $1.44 per share, resulting in a total value of $50,418.
According to the filing, the sale was necessary to cover tax withholding obligations related to the vesting of restricted stock units (RSUs). This transaction was a "sell to cover" action, as outlined in the terms of the applicable RSU award agreement. Following the sale, Duffy retains ownership of 348,630 shares in Olaplex Holdings.
In other recent news, Olaplex Holdings Inc. reported its fourth-quarter 2024 earnings, which met Wall Street expectations with an earnings per share (EPS) of $0.01 and revenue of $100.7 million, surpassing the anticipated $87.51 million. Despite the revenue exceeding forecasts, the company experienced a year-over-year decline in net sales for both the quarter and the full year. Jefferies and Piper Sandler have both adjusted their price targets for Olaplex, with Jefferies reducing it to $1.40 and Piper Sandler to $1.50, while maintaining Hold and Neutral ratings, respectively. Jefferies noted that Olaplex’s sales and EBITDA surpassed estimates, but the company’s gross margin and EBITDA margin percentages fell short of expectations for fiscal year 2025. Piper Sandler highlighted Olaplex’s investments in team expansion, research and development, and marketing as factors contributing to top-line growth, with expectations of returning to positive figures later in 2025. Olaplex’s management remains focused on strategic initiatives to foster long-term sustainable growth, with plans to launch new products annually and strengthen its U.S. market presence. The company’s strong cash position, with cash and equivalents rising to $586 million, supports its ongoing efforts to innovate and expand.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.